Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspension (Par) Compared to CIPRODEX® (Ciprofloxacin 0.3%/Dexamethasone 0.1%) Sterile Otic Suspension (Alcon) in the Treatment of Adults With Acute Bacterial Otitis Externa
Conditions
Interventions
Ciprofloxacin/Dexamethasone
Ciprodex (R)
+1 more
Locations
32
United States
James Donivan Gordon, MD
Tucson, Arizona, United States
Nea Baptist Clinic
Jonesboro, Arkansas, United States
Applied Reserch Center
Little Rock, Arkansas, United States
John Champlin, MD
Carmichael, California, United States
Aliance Research
Long Beach, California, United States
ENT of South Florida
Boyton Beach, Florida, United States
Start Date
July 1, 2013
Primary Completion Date
February 1, 2015
Completion Date
March 1, 2015
Last Updated
October 18, 2016
NCT03196973
NCT02801370
NCT00523120
NCT00980876
NCT01535560
Lead Sponsor
Par Pharmaceutical, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions